Showing results (921-930 of 952) with videos related to

Sort By:
Pageof 96
Human Mutation|February 4, 2014
Expanding the mutational spectrum of CRLF1 in Crisponi/CISS1 syndromeRoberta Piras, Francesca Chiappe, Ilaria La Torraca, et al.
Cancer Research|February 13, 2020
Skipping Nonsense to Maintain Function: The Paradigm of <i>BRCA2</i> Exon 12Laëtitia Meulemans, Romy L S Mesman, Sandrine M Caputo, et al.
Plos Biology|April 14, 2025
Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signalingMarion Régnier, Arnaud Polizzi, Tiffany Fougeray, et al.
Blood|November 9, 2020
A fixed-duration, measurable residual disease-guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trialAnne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier, et al.
Blood Advances|April 7, 2023
A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trialAnne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier, et al.
The Oncologist|January 22, 2026
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysisOgechukwu A Asogwa, Linda Dirven, Neil K Aaronson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2024
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIAMazyar Shadman, Talha Munir, Tadeusz Robak, et al.
Nature Communications|December 10, 2024
Genomic perspective on the bacillus causing paratyphoid B feverJane Hawkey, Lise Frézal, Alicia Tran Dien, et al.
The Lancet. Haematology|July 21, 2019
Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trialAnne-Sophie Michallet, Marie-Sarah Dilhuydy, Fabien Subtil, et al.
Seminars in Arthritis and Rheumatism|October 22, 2024
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohortLuis Alonso González, Guillermina B Harvey, Rosana Quintana, et al.
Pageof 96